Top medical news headlines for the week 36

Supplement plus chemotherapy boosts pancreatic cancer survival

When added to standard chemotherapy, a clinical version of the dietary supplement L-glutamine improved survival in an early-phase trial of patients with advanced pancreatic cancer. The study, led by Cedars-Sinai Health Sciences ...

Snacking is not as unhealthy as you might think

Snacking, it turns out, is not all about chips, cookies and chocolate. Dutch millennials often consume nutritious foods, such as fruit, bread and yogurt, between their main meals. This is one of the findings from the doctoral ...

Some hair loss in men is linked to weight loss drug use

Men already genetically at risk for the most common form of hair loss have a 7% added risk of losing their hair if they use drugs like Ozempic, Wegovy and Zepbound for type 2 diabetes and obesity, a new study shows.

AI scribes may fail to capture patients' experiences

The use of artificial intelligence (AI) tools to take notes can change the nature of interactions between patients and clinicians, sometimes missing vital information, according to the results of a new review.

Gut-derived bacterial molecule may drive severe liver disease

Researchers at the University of Oslo and Oslo University Hospital, together with international collaborators, have discovered that a small molecule made exclusively by gut bacteria can actively drive disease in the bile ...

Laughter therapy can help people with COPD breathe more easily

A clinical trial for patients with chronic obstructive pulmonary disease (COPD) shows that laughter therapy can reduce breathing difficulties and is as effective as more traditional breathing exercises. The research was presented ...

Brain signaling mechanism may explain clozapine weight gain

Researchers at UT Southwestern Medical Center have identified a key brain signaling pathway that appears to drive the substantial weight gain often associated with clozapine, a widely used antipsychotic medication. The preclinical ...